EMA Authorised: Fylrevy (estetrol monohydrate) — Gedeon Richter Plc.

View source ↗

Summary

EMA authorised Fylrevy (estetrol monohydrate) for menopausal hormone therapy. Gedeon Richter Plc. is the marketing authorisation holder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• Fylrevy (estetrol monohydrate)

Snippet

Status: Authorised. Therapeutic area: Menopause. MAH: Gedeon Richter Plc.. Decision date: 26/03/2026